NEW YORK – Health technology company Vibrent Health and University of Maryland Medicine said on Thursday that they are collaborating to create the All of Maryland Precision Health Initiative, a digital platform to study how genes and other factors affect health.
The study’s long-term aim is to be able to tailor treatments to patients’ individual health profiles. It will leverage Vibrent’s experience developing the NIH-sponsored All of Us Research Program, which launched in 2018.
Investigators seek a broad set of health data, including genomic information, from up to 250,000 volunteers from across Maryland, with emphasis on underserved populations that typically experience greater rates of illness and shorter average lifespans due to healthcare disparities. This data is expected to help researchers understand how human genomic variation relates to disease and treatment.
Read more at Genome Web.
